Request Sample Inquiry
Facial Injectable Market

Facial Injectable Market

Facial Injectable Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

148

Base Year:

2022

Date

Jun - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1630

Segments Covered
  • By Product By Product Collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Polymer Fillers
  • By Application By Application Aesthetics, Therapeutics
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 4.37 Billion
Revenue 2030Revenue 2030: USD 8.82 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 9.20%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Facial Injectable Market - Segment Analysis
    1. Overview
    2. Global Facial Injectable Market, 2016 - 2028 (USD Million)
    3. Global Facial Injectable Market - by Product
      1. By Collagen
      2. By Hyaluronic Acid (HA)
      3. By Botulinum Toxin Type A
      4. By Calcium Hydroxylapatite (CaHA)
      5. By Polymer Fillers
    4. Global Facial Injectable Market - by Application
      1. By Aesthetics
      2. By Therapeutics
    5. Global Facial Injectable Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Facial Injectable Market - Segment Analysis
    1. Overview
    2. North America Facial Injectable Market, 2016 - 2028 (USD Million)
    3. North America Facial Injectable Market, by Product
      1. By Collagen
      2. By Hyaluronic Acid (HA)
      3. By Botulinum Toxin Type A
      4. By Calcium Hydroxylapatite (CaHA)
      5. By Polymer Fillers
    4. North America Facial Injectable Market, by Application
      1. By Aesthetics
      2. By Therapeutics
    5. North America Facial Injectable Market, by Country
      1. U.S.
        1. U.S. Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. U.S. Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      2. Canada
        1. Canada Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Canada Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      3. Mexico
        1. Mexico Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Mexico Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
  5. Europe Facial Injectable Market - Segment Analysis
    1. Overview
    2. Europe Facial Injectable Market, 2016 - 2028 (USD Million)
    3. Europe Facial Injectable Market, by Product
      1. By Collagen
      2. By Hyaluronic Acid (HA)
      3. By Botulinum Toxin Type A
      4. By Calcium Hydroxylapatite (CaHA)
      5. By Polymer Fillers
    4. Europe Facial Injectable Market, by Application
      1. By Aesthetics
      2. By Therapeutics
    5. Europe Facial Injectable Market, by Country
      1. Germany
        1. Germany Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Germany Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      2. UK
        1. UK Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. UK Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      3. France
        1. France Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. France Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      4. Spain
        1. Spain Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Spain Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      5. Italy
        1. Italy Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Italy Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      6. BENELUX
        1. BENELUX Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. BENELUX Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      7. Rest of Europe
        1. Rest Of Europe Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Rest Of Europe Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
  6. Asia Pacific Facial Injectable Market - Segment Analysis
    1. Overview
    2. Asia Pacific Facial Injectable Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Facial Injectable Market, by Product
      1. By Collagen
      2. By Hyaluronic Acid (HA)
      3. By Botulinum Toxin Type A
      4. By Calcium Hydroxylapatite (CaHA)
      5. By Polymer Fillers
    4. Asia Pacific Facial Injectable Market, by Application
      1. By Aesthetics
      2. By Therapeutics
    5. Asia Pacific Facial Injectable Market, by Country
      1. China
        1. China Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. China Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      2. Japan
        1. Japan Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Japan Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      3. India
        1. India Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. India Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      4. South Korea
        1. South Korea Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. South Korea Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      5. South East Asia
        1. South East Asia Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. South East Asia Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Rest of Asia Pacific Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
  7. Latin America Facial Injectable Market - Segment Analysis
    1. Overview
    2. Latin America Facial Injectable Market, 2016 - 2028 (USD Million)
    3. Latin America Facial Injectable Market, by Product
      1. By Collagen
      2. By Hyaluronic Acid (HA)
      3. By Botulinum Toxin Type A
      4. By Calcium Hydroxylapatite (CaHA)
      5. By Polymer Fillers
    4. Latin America Facial Injectable Market, by Application
      1. By Aesthetics
      2. By Therapeutics
    5. Latin America Facial Injectable Market, by Country
      1. Brazil
        1. Brazil Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Brazil Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      2. Argentina
        1. Argentina Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Argentina Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      3. Rest of Latin America
        1. Rest of Latin America Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Rest of Latin America Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
  8. Middle East & Africa Facial Injectable Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Facial Injectable Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Facial Injectable Market, by Product
      1. By Collagen
      2. By Hyaluronic Acid (HA)
      3. By Botulinum Toxin Type A
      4. By Calcium Hydroxylapatite (CaHA)
      5. By Polymer Fillers
    4. Middle East & Africa Facial Injectable Market, by Application
      1. By Aesthetics
      2. By Therapeutics
    5. Middle East & Africa Facial Injectable Market, by Country
      1. GCC Countries
        1. GCC Countries Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. GCC Countries Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      2. South Africa
        1. South Africa Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. South Africa Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Facial Injectable Market, By Product
          1. By Collagen
          2. By Hyaluronic Acid (HA)
          3. By Botulinum Toxin Type A
          4. By Calcium Hydroxylapatite (CaHA)
          5. By Polymer Fillers
        2. Rest of Middle East & Africa Facial Injectable Market, By Application
          1. By Aesthetics
          2. By Therapeutics
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Ipsen
    2. Merz Pharma
    3. Suneva Medical Inc.
    4. Medytox Inc.
    5. Sinclair Pharma
    6. Bloomage BioTechnology Corporation Limited
    7. Anika Therapeutics Inc.
    8. Prollenium Medical Technologies
    9. Galderma
    10. Allergan Inc.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 06-Jun-2022
Facial Injectable Market to Reach Valuation of USD 7.5 Billion by 2028 - Increasing Demand for Facial Injectable Market for Enhancing the Aesthetic Beauty to Drive the Market Growth
FAQ
Frequently Asked Question

  • The global Facial Injectable valued at USD 4.37 Billion in 2022 and is expected to reach USD 8.82 Billion in 2030 growing at a CAGR of 9.20%.

  • The prominent players in the market are Ipsen, Merz Pharma, Suneva Medical Inc., Medytox Inc., Sinclair Pharma, Bloomage BioTechnology Corporation Limited, Anika Therapeutics Inc., Prollenium Medical Technologies, Galderma, Allergan Inc..

  • The market is project to grow at a CAGR of 9.20% between 2023 and 2030.

  • The driving factors of the Facial Injectable include

    • Rising Demand for Facial Injectables to Enhance Aesthetic Beauty

  • North America was the leading regional segment of the Facial Injectable in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy